Transgenomic to Hold Second Quarter Financial Results Conference Call on August 6, 2014

Business Wire

OMAHA, Neb.--(BUSINESS WIRE)--

Transgenomic, Inc. (TBIO) today announced the following Webcast:

   
What: Transgenomic, Inc. Second Quarter 2014 Financial Results and Business Update Conference Call
 
When: Wednesday, August 6, 2014 @ 5:00 p.m. Eastern
 
Where:

http://www.videonewswire.com/event.asp?id=100213

 
How: Live over the Internet -- Simply log on to the web at the address above.
 
Contact: Investor Relations, 203-907-2293
 

To access the call via telephone, dial 866-952-1908 from the U.S. and Canada or 785-424-1827 for international participants and enter conference ID TRANS. A telephone replay will be available from 8:00 p.m. Eastern Time on August 6, 2014 through 11:59 p.m. Eastern Time on August 20, 2014 by dialing 800-723-1517 (domestic) or 402-220-2659 (international).

About Transgenomic, Inc.

Transgenomic, Inc. is a global biotechnology company advancing personalized medicine in cardiology, oncology, and inherited diseases through advanced diagnostic technologies, such as its revolutionary ICE COLD-PCRTM and its unique genetic tests provided through its Patient Testing business. The company also provides specialized clinical and research services to biopharmaceutical companies developing targeted therapies and sells equipment, reagents and other consumables for applications in molecular testing and cytogenetics. Transgenomic’s diagnostic technologies are designed to improve medical diagnoses and patient outcomes.

Contact:
Investor Contact
Argot Partners
Susan Kim, 212-600-1902
susan@argotpartners.com
or
Media Contact
BLL Partners LLC
Barbara Lindheim, 212-584-2276
blindheim@bllbiopartners.com
or
Company Contact
Transgenomic, Inc.
Mark Colonnese, 203-907-2242
investorrelations@transgenomic.com

Rates

View Comments (0)